Single Center Experience on Screening Oncology Patients for Covid-19 Before Anti-Cancer Treatment

OZTURK, Ali Vefa; ÇEVİK, Özkan Esin; YIR, Asiye; SABET, Soheyl; GURCAN, Nagihan Inan; namal, esat; DİNÇ, Merve Nur; Tokat, Yaman; ÇİFTÇİ, Cavlan; SOKMEN, Bedriye Koyuncu; SAGLAM, Sezer; DEMIR, Safiye Koculu

Single Center Experience on Screening Oncology Patients for Covid-19 Before Anti-Cancer Treatment

Esat NAMAL, (Demiroğlu Bilim Üniversitesi Tıp Fakültesi Tıbbi Onkoloji Anabilim Dalı,TÜRKİYE)

Merve Nur DİNÇ, (Demiroğlu Bilim Üniversitesi Tıp Fakültesi Tıbbi Onkoloji Anabilim Dalı)

Sezer SAGLAM, (Demiroğlu Bilim Üniversitesi Tıp Fakültesi Tıbbi Onkoloji Anabilim Dalı,TÜRKİYE)

Ali Vefa OZTURK, (Demiroğlu Bilim Üniversitesi Tıp Fakültesi Göğüs Hastalıkları Anabilim Dalı,TÜRKİYE)

Safiye Koculu DEMIR, (Demiroğlu Bilim Üniversitesi Tıp Fakültesi Enfeksiyon Hastalıkları Anabilim Dalı,TÜRKİYE)

Asiye YIR, (Demiroğlu Bilim Üniversitesi Tıp Fakültesi Enfeksiyon Hastalıkları Anabilim Dalı,Türkiye)

Özkan Esin ÇEVİK, (Demiroğlu Bilim Üniversitesi Tıp Fakültesi Enfeksiyon Hastalıkları Anabilim Dalı,Türkiye)

Soheyl SABET, (Demiroğlu Bilim Üniversitesi Tıp Fakültesi Radyoloji Anabilim Dalı,Türkiye)

Bedriye Koyuncu SOKMEN, (Demiroğlu Bilim Üniversitesi Tıp Fakültesi Radyoloji Anabilim Dalı,Türkiye)

Nagihan Inan GURCAN, (Demiroğlu Bilim Üniversitesi Tıp Fakültesi Radyoloji Anabilim Dalı, Türkiye)

Yaman TOKAT, (Demiroğlu Bilim Üniversitesi Tıp Fakültesi Karaciğer Nakli Anabilim Dalı,Türkiye)

Cavlan ÇİFTÇİ, (Demiroğlu Bilim Üniversitesi, Tıp Fakültesi, Kardiyoloji Anabilim Dalı, İstanbul, TÜRKİYE)

Diğer Yazarlar

Uluslararası Hematoloji-Onkoloji Dergisi

0 0

Yıl: 2020 Cilt: 30 Sayı: 4 Sayfa Aralığı: 207 - 212 Metin Dili: İngilizce İndeks Tarihi: 09-06-2021

Single Center Experience on Screening Oncology Patients for Covid-19 Before Anti-Cancer Treatment

Öz:

The most important factor in the transmission of the COVID-19 is asymptomatic carriers. We’ve tested all oncology patients , that receive anti-cancer therapy, for COVID-19. We aimed to determine the rate of asymptomatic carriers, and analyze the clinical and ra-diological findings of infected patients. Oncology patients who have indications of receiving anti-cancer treatment in the hospital were tested for COVID-19, two day prior to their treatment even if they were asymptomatic by collecting nasopharyngeal and oropharyngeal swab specimens for RT-PCR for viral RNA detection. Positive patients, underwent inspiratory phase of chest computed tomography examination. Infected patients were given the recommended treatment for COVID-19. PCR test was positive in 28 of 312 patients that we tested, and the positivity rate was 8.9%. Three patients (10.7%) had symptoms, 25 patients (89.3%) had no symptoms. Covid-19 testing before anti-cancer treatment may be recommended in order to continue their treatment without any problems and to prevent the risk of transmission due to the high rate of asymptomatics in infected patients.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1.Surveillance case definitions for human infection with novel coronavirus (nCoV) Interim guidance v2 15 January 2020 WHO/2019-nCoV/Surveillance/v2020.2
2.World Health Organization. Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-febru-ary-2020 Accessed on February 12, 2020.
3.World Health Organization. Coronavirus disease (COVID-19) Pandemic. www.who.int/emergencies/diseases/novel-coro-navirus-2019.
4.Perrotta F, Corbi G, Mazzeo G, et al. COVID-19 and the el-derly: insights into pathogenesis and clinical decision-making. Aging Clin Exp Res 32: 1599-1608, 2020.
5.World Health Organization. Modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recom-mendations. www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implica-tions-for-ipc-precaution-recommendations.
6.Onder G, Rezza G, Brusaferro S. Case-fatality rate and char-acteristics of patients dying in relation to COVID-19 in Italy. JAMA 323: 1775-1776, 2020.
7.Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 213: 335-337, 2020.
8.General Information about COVID-19 & Cancer. https://www.asco.org/asco-coronavirus-resources/care-individuals-cancer-during-covid-19/general-information-about-covid-19.
9.COVID-19 Pandemisinde Hekimlerin Almalari Gereken Kisi-sel Onlemler. https://www.kanser.org/saglik/haberler/covid-19-pandemisinde-hekimlerin-almalari-gereken-kisisel-onlem-ler/2129.
10.European Society of Medical Oncology. Cancer patient man-agement during the COVID-19 pandemic. European Soci-ety of Medical Oncology Web Site. https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic. 2020. Accessed April 17, 2020.
11.Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19. https://www.idsociety.org/practice-guideline/covid-19-guideline-diagnostics/ Accessed on May 08, 2020.
12.Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneu-monia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395: 514-23, 2020.
13.https://www.who.int/docs/default-source/coronavi-ruse/situation-reports/20200124-sitrep-4-2019-ncov.pdf?sfvrsn=9272d086_8
14.Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill 25:2000180, 2020.
15.Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a de-scriptive study. Lancet Infect Dis 20: 425-434, 2020.
16.Zhao W, Zhong Z, Xie X, et al. Relation between chest CT findings and clinical conditions of coronavirus disease (COV-ID-19) pneumonia. AJR 214: 1072-1077, 2020
17.Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8: 420-422, 2020.
18.Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: In-tegrating immunity’s roles in cancer suppression and promo-tion. Science 331: 1565-1570, 2011

APA	namal e, DİNÇ M, SAGLAM S, OZTURK A, DEMIR S, YIR A, ÇEVİK Ö, SABET S, SOKMEN B, GURCAN N, Tokat Y, ÇİFTÇİ C (2020). Single Center Experience on Screening Oncology Patients for Covid-19 Before Anti-Cancer Treatment. , 207 - 212.
Chicago	namal esat,DİNÇ Merve Nur,SAGLAM Sezer,OZTURK Ali Vefa,DEMIR Safiye Koculu,YIR Asiye,ÇEVİK Özkan Esin,SABET Soheyl,SOKMEN Bedriye Koyuncu,GURCAN Nagihan Inan,Tokat Yaman,ÇİFTÇİ Cavlan Single Center Experience on Screening Oncology Patients for Covid-19 Before Anti-Cancer Treatment. (2020): 207 - 212.
MLA	namal esat,DİNÇ Merve Nur,SAGLAM Sezer,OZTURK Ali Vefa,DEMIR Safiye Koculu,YIR Asiye,ÇEVİK Özkan Esin,SABET Soheyl,SOKMEN Bedriye Koyuncu,GURCAN Nagihan Inan,Tokat Yaman,ÇİFTÇİ Cavlan Single Center Experience on Screening Oncology Patients for Covid-19 Before Anti-Cancer Treatment. , 2020, ss.207 - 212.
AMA	namal e,DİNÇ M,SAGLAM S,OZTURK A,DEMIR S,YIR A,ÇEVİK Ö,SABET S,SOKMEN B,GURCAN N,Tokat Y,ÇİFTÇİ C Single Center Experience on Screening Oncology Patients for Covid-19 Before Anti-Cancer Treatment. . 2020; 207 - 212.
Vancouver	namal e,DİNÇ M,SAGLAM S,OZTURK A,DEMIR S,YIR A,ÇEVİK Ö,SABET S,SOKMEN B,GURCAN N,Tokat Y,ÇİFTÇİ C Single Center Experience on Screening Oncology Patients for Covid-19 Before Anti-Cancer Treatment. . 2020; 207 - 212.
IEEE	namal e,DİNÇ M,SAGLAM S,OZTURK A,DEMIR S,YIR A,ÇEVİK Ö,SABET S,SOKMEN B,GURCAN N,Tokat Y,ÇİFTÇİ C "Single Center Experience on Screening Oncology Patients for Covid-19 Before Anti-Cancer Treatment." , ss.207 - 212, 2020.
ISNAD	namal, esat vd. "Single Center Experience on Screening Oncology Patients for Covid-19 Before Anti-Cancer Treatment". (2020), 207-212.

APA	namal e, DİNÇ M, SAGLAM S, OZTURK A, DEMIR S, YIR A, ÇEVİK Ö, SABET S, SOKMEN B, GURCAN N, Tokat Y, ÇİFTÇİ C (2020). Single Center Experience on Screening Oncology Patients for Covid-19 Before Anti-Cancer Treatment. Uluslararası Hematoloji-Onkoloji Dergisi, 30(4), 207 - 212.
Chicago	namal esat,DİNÇ Merve Nur,SAGLAM Sezer,OZTURK Ali Vefa,DEMIR Safiye Koculu,YIR Asiye,ÇEVİK Özkan Esin,SABET Soheyl,SOKMEN Bedriye Koyuncu,GURCAN Nagihan Inan,Tokat Yaman,ÇİFTÇİ Cavlan Single Center Experience on Screening Oncology Patients for Covid-19 Before Anti-Cancer Treatment. Uluslararası Hematoloji-Onkoloji Dergisi 30, no.4 (2020): 207 - 212.
MLA	namal esat,DİNÇ Merve Nur,SAGLAM Sezer,OZTURK Ali Vefa,DEMIR Safiye Koculu,YIR Asiye,ÇEVİK Özkan Esin,SABET Soheyl,SOKMEN Bedriye Koyuncu,GURCAN Nagihan Inan,Tokat Yaman,ÇİFTÇİ Cavlan Single Center Experience on Screening Oncology Patients for Covid-19 Before Anti-Cancer Treatment. Uluslararası Hematoloji-Onkoloji Dergisi, vol.30, no.4, 2020, ss.207 - 212.
AMA	namal e,DİNÇ M,SAGLAM S,OZTURK A,DEMIR S,YIR A,ÇEVİK Ö,SABET S,SOKMEN B,GURCAN N,Tokat Y,ÇİFTÇİ C Single Center Experience on Screening Oncology Patients for Covid-19 Before Anti-Cancer Treatment. Uluslararası Hematoloji-Onkoloji Dergisi. 2020; 30(4): 207 - 212.
Vancouver	namal e,DİNÇ M,SAGLAM S,OZTURK A,DEMIR S,YIR A,ÇEVİK Ö,SABET S,SOKMEN B,GURCAN N,Tokat Y,ÇİFTÇİ C Single Center Experience on Screening Oncology Patients for Covid-19 Before Anti-Cancer Treatment. Uluslararası Hematoloji-Onkoloji Dergisi. 2020; 30(4): 207 - 212.
IEEE	namal e,DİNÇ M,SAGLAM S,OZTURK A,DEMIR S,YIR A,ÇEVİK Ö,SABET S,SOKMEN B,GURCAN N,Tokat Y,ÇİFTÇİ C "Single Center Experience on Screening Oncology Patients for Covid-19 Before Anti-Cancer Treatment." Uluslararası Hematoloji-Onkoloji Dergisi, 30, ss.207 - 212, 2020.
ISNAD	namal, esat vd. "Single Center Experience on Screening Oncology Patients for Covid-19 Before Anti-Cancer Treatment". Uluslararası Hematoloji-Onkoloji Dergisi 30/4 (2020), 207-212.